524400 — Ishita Drugs And Industries Income Statement
0.000.00%
Last trade - 00:00
- IN₹210.67m
- IN₹153.12m
- IN₹120.72m
- 68
- 33
- 52
- 50
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 90.9 | 148 | 139 | 141 | 121 |
Cost of Revenue | |||||
Gross Profit | 26.9 | 33.9 | 36.6 | 39.2 | 35.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 87.3 | 142 | 132 | 131 | 114 |
Operating Profit | 3.6 | 5.86 | 7.72 | 9.61 | 6.32 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.63 | 7.13 | 10.5 | 10.4 | 7.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.52 | 5.47 | 8.3 | 8.05 | 5.77 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.52 | 5.47 | 8.3 | 8.05 | 5.77 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.52 | 5.47 | 8.3 | 8.05 | 5.77 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.18 | 1.83 | 2.77 | 2.69 | 1.93 |